`Covovax not approved in country of origin yet`: Govt panel seeks additional data from SII

The Serum Institute of India (SII) had put in an application to the Drugs Controller General of India (DCGI) in October for grant of market authorisation of Covovax for restricted use in emergency situations.

from Zee News :India National https://ift.tt/3D0ZnNg